HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Tuberculosis in hemodialysis patients in Tunisia].

AbstractBACKGROUND:
Because of the immunity depression, patients with chronic renal failure undergoing haemodialysis are at increased risk for developing infections, Mycobacterium tuberculosis (MTb) in particular.
OBJECTIVE:
To evaluate, in a prospective longitudinal study over 36 months period, the frequency of Tb among these patients and underline the diagnostic difficulties.
PATIENTS AND METHODS:
Sixty dialysis patients were interested. The Tb assessment comprised: a questionnaire, a meticulous clinical examination, a chest X-ray, a tuberculin skin testing, as well as MT bacilli screening in biological fluids.
RESULTS:
Tb was seen in six among dialysis patients(10%), this rate represents 15 times the general population tuberculosis incidence in our country (23/100,000). Tb has occurred early compared to the beginning of the haemodialysis. The Tb localizations were: 4 cases of extra-pulmonary tuberculosis (3 peritoneal and one ganglionic) and only 2 cases of pleuro-pulmonary localization. The positive diagnosis represents a real problem: no bacteriological confirmation in all patients and only in one, the histological diagnosis was obtained.
CONCLUSION:
There was a high rate of tuberculosis in our study. The prognosis appears to be closely related to therapeutic precocity, thus specific chemotherapy started sometimes without diagnostic confirmation.
AuthorsE Hassine, K Marniche, J Hamida, K Hassine, A Bouaziz, M A Ben Mustapha, A Chabbou, M Dhahri
JournalNephrologie (Nephrologie) Vol. 23 Issue 3 Pg. 135-40 ( 2002) ISSN: 0250-4960 [Print] Switzerland
Vernacular TitleTuberculose des patients hémodialysés en Tunisie.
PMID12087811 (Publication Type: Comparative Study, English Abstract, Journal Article)
Topics
  • Humans
  • Incidence
  • Prognosis
  • Renal Dialysis (adverse effects, statistics & numerical data)
  • Tuberculosis (epidemiology, etiology)
  • Tunisia (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: